Autoimmunity, hypogammaglobulinemia, lymphoproliferation, and mycobacterial disease in patients with activating mutations in STAT3

STAT3激活突变患者的自身免疫性疾病、低丙种球蛋白血症、淋巴增生和分枝杆菌病

阅读:6
作者:Emma M Haapaniemi ,Meri Kaustio ,Hanna L M Rajala ,Arjan J van Adrichem ,Leena Kainulainen ,Virpi Glumoff ,Rainer Doffinger ,Heikki Kuusanmäki ,Tarja Heiskanen-Kosma ,Luca Trotta ,Samuel Chiang ,Petri Kulmala ,Samuli Eldfors ,Riku Katainen ,Sanna Siitonen ,Marja-Liisa Karjalainen-Lindsberg ,Panu E Kovanen ,Timo Otonkoski ,Kimmo Porkka ,Kaarina Heiskanen ,Arno Hänninen ,Yenan T Bryceson ,Raija Uusitalo-Seppälä ,Janna Saarela ,Mikko Seppänen ,Satu Mustjoki ,Juha Kere

Abstract

The signal transducer and activator of transcription (STAT) family of transcription factors orchestrate hematopoietic cell differentiation. Recently, mutations in STAT1, STAT5B, and STAT3 have been linked to development of immunodysregulation polyendocrinopathy enteropathy X-linked-like syndrome. Here, we immunologically characterized 3 patients with de novo activating mutations in the DNA binding or dimerization domains of STAT3 (p.K392R, p.M394T, and p.K658N, respectively). The patients displayed multiorgan autoimmunity, lymphoproliferation, and delayed-onset mycobacterial disease. Immunologically, we noted hypogammaglobulinemia with terminal B-cell maturation arrest, dendritic cell deficiency, peripheral eosinopenia, increased double-negative (CD4(-)CD8(-)) T cells, and decreased natural killer, T helper 17, and regulatory T-cell numbers. Notably, the patient harboring the K392R mutation developed T-cell large granular lymphocytic leukemia at age 14 years. Our results broaden the spectrum of phenotypes caused by activating STAT3 mutations, highlight the role of STAT3 in the development and differentiation of multiple immune cell lineages, and strengthen the link between the STAT family of transcription factors and autoimmunity.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。